Effect of folic acid on homocysteine and insulin resistance of overweight and obese children and adolescents

Dehkordi, Elham Hashemi; Sedehi, Morteza; Shahraki, Zohre Gholipour; Najafi, Reza

Effect of folic acid on homocysteine and insulin resistance of overweight and obese children and adolescents

Authors

¹ Department of Pediatrics Endocrinology, Shahrekord University of Medical Sciences, Shahrekord; Department of Pediatrics Endocrinology, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran

³ School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

Abstract

Background: Considering the increasing trend of childhood obesity and subsequent burden of the disease in Iran and other countries and importance of early life intervention for achieving sustained effect on health of children and adolescents, this study aimed to investigate the effect of two different dose of folic acid on homocysteine (Hcy) level and insulin resistance of obese children.
Materials and Methods: In this randomized, double-blind controlled clinical trial study, 60 obese and overweight children aged 5–12 years were enrolled. Selected obese children randomly allocated in two interventional (1 mg/day folic acid and 5 mg/day folic acid, for 8 weeks) and one control groups. Biochemical measurements including folic acid, Hcy, insulin and insulin resistance were measured between and within groups before and after trial.

Results: In each group, 20 obese children were studied. The three groups were age and sex matched. After folic acid administration, mean of Hcy, insulin resistance and insulin decreased significantly in two groups which folic acid administrated with two different doses (P < 0.05). The reduction in studied biochemical variables was similar in two interventional groups (1 and 5 mg folic acid daily) (P > 0.05). Mean differences for Hcy, insulin resistance and insulin, in two intervention groups were significantly higher than the control group (P < 0.0001). Mean differences of Hcy, insulin resistance and insulin, in two intervention groups were not different significantly (P > 0.05).
Conclusion: The findings of current trial showed that folic acid in two studied doses could be a safe and effective supplement for obese children to reduce Hcy level and insulin resistance, which consequently could prevent obesity-related complications including cardiovascular and metabolic disorders.

Keywords

References

1.	Daniels SR. Complications of obesity in children and adolescents. Int J Obes (Lond) 2009;33 Suppl 1:S60-5.
2.	Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Pediatr Obes 2006;1:11-25.
3.	de Onis M, Blössner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010;92:1257-64.
4.	Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: The Bogalusa Heart Study. J Pediatr 2007;150:12-17.e2.
5.	Park SB, Georgiades A. Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea. J Korean Med Sci 2013;28:1015-20.
6.	Cesari M, Zanchetta M, Burlina A, Pedon L, Maiolino G, Sticchi D, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 2005;25:115-21.
7.	Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109 23 Suppl 1:III15-9.
8.	Fonseca VA, Fink LM, Kern PA. Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 2003;167:105-9.
9.	Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: The Third National Health and Nutrition Examination Survey. Nutr J 2003;2:6.
10.	Atabek ME, Bağcı Z, Pirgon Ö, Erkul İ. Plasma total homocysteine levels in childhood obesity. Turk J Endocrinol Metab 2004;3:107-11.
11.	Martos R, Valle M, Morales R, Cañete R, Gavilan MI, Sánchez-Margalet V. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Metabolism 2006;55:72-7.
12.	Garcia G, Trejos J, Restrepo B, Landázuri P. Homocysteine, folate and vitamin B12 in Colombian patients with coronary disease. Arq Bras Cardiol 2007;89:71-6, 79-85.
13.	Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006;30:1197-202.
14.	Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 2011;94:33-8.
15.	Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2012;98:151-8.
16.	Lee YS. Consequences of childhood obesity. Ann Acad Med Singapore 2009;38:75-7.
17.	Garanty-Bogacka B, Syrenicz M, Szolomicka-Kurzawa P, Gebala A, Goral J, Krupa B. Correlation between serum homocysteine levels and selected atherosclerosis risk factors in children and adolescents with simple obesity. Przegl Lek 2006;63:645-9.
18.	Codoñer-Franch P, Murria-Estal R, Tortajada-Girbés M, del Castillo-Villaescusa C, Valls-Bellés V, Alonso-Iglesias E. New factors of cardiometabolic risk in severely obese children: Influence of pubertal status. Nutr Hosp 2010;25:845-51.
19.	Gallistl S, Sudi K, Mangge H, Erwa W, Borkenstein M. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000;23:1348-52.
20.	Song Y, Cook NR, Albert CM, Van Denburgh M, Manson JE. Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: A randomized, controlled trial. Diabetes 2009;58:1921-8.
21.	Peña AS, Wiltshire E, Gent R, Piotto L, Hirte C, Couper J. Folic acid does not improve endothelial function in obese children and adolescents. Diabetes Care 2007;30:2122-7.
22.	Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I. Oral supplementation of folic acid for two months reduces total serum homocysteine levels in hyperhomocysteinemic Greek children. Hippokratia 2010;14:105-8.
23.	Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000;26:341-8.
24.	Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008;87:517-33.
25.	Tamadon MR, Jamshidi L, Soliemani A, Ghorbani R, Malek F, Malek M. Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis. Iran J Kidney Dis 2011;5:93-6.
26.	Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol 1999;51:108-15.

Advanced Biomedical Research